Studies on primary samples from JMML patients have confirmed that NF1 acts as a tumor suppressor by negatively regulating Ras proteins in immature hematopoietic cells [37, 39, 40]. The gene discussed is NF1; the disease is juvenile myelomonocytic leukemia.